News

Article

Alcon presenting at APACRS 2025

Author(s):

Key Takeaways

  • Alcon will present four symposia and ten scientific presentations at the APACRS Annual Meeting, focusing on cataract and refractive surgery innovations.
  • Key studies include the evaluation of Vivity IOLs in patients with mild irregular astigmatism and the impact of intraocular pressure on retinal perfusion during cataract surgery.
SHOW MORE

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved patient outcomes.

Atal Pedestrian Bridge, a foot-over bridge on Sabarmati river, night view, in Ahmedabad, Gujrat, India.. (Image credit: ©RealityImages/AdobeStock)

(Image credit: ©RealityImages/AdobeStock)

Alcon announced presentations during the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone booth.1 APACRS is being held August 21-23, 2025, at the Mahatma Mandir Convention and Exhibition Centre in Ahmedabad, India.

“APACRS brings together leading experts and their insights from across the region, creating an ideal environment to engage in critical topics such as the evolving needs of cataract care in the aging population,” Massimo Cerrone, Vice President, Surgical for Alcon Asia Pacific, said in a press release.1

“Through a dynamic agenda, surgeons can explore Alcon’s latest innovations and their value through clinical evidence, real-world insights, and peer experience across Asia-Pacific.”

Key data Alcon is presenting at APACRS 2025

The company will be presenting an e-poster on the prospective study, “To Evaluate the Visual Outcomes and Patient Satisfaction After Bilateral Vivity IOL Implantation in Patients with Mild Irregular Astigmatism.” This study, conducted by Ashvin Agarwal, MD, is one of more than 10 clinical studies supporting Alcon’s Vivity. Vivity is an extended depth of focus (EDOF) intraocular lens (IOL) studied in special populations with various comorbidities. Analyses of Vivity show patient satisfaction across the more than 700 patients.

Shail Vasavada, DO, DNB, FICO, will be presenting a prospective, randomized, single-masked, single-center study titled, “Retinal Perfusion During Cataract Surgery with Varying Intraocular Pressure in Comorbid Eyes.” The data from the study underlines the benefits of performing cataract surgery at more physiologic IOP in patients with diabetic retinopathy (DR).1

In addition to the presentations, Alcon will host four symposia.1

  1. Alcon UNITY VCS Launch Symposium: This symposium will be held exclusively for India, marking the official introduction of UNITY VCS (Vitreoretinal Cataract System) and UNITY CS (Cataract System) to the Indian market.
  2. Alcon IOL Symposium: This session will give an overview of the Clareon Collection as a comprehensive IOL portfolio, discuss optical differentiation and performance of newer EDOF IOLs, and highlight the role of digital image guidance in toric correction.
  3. Alcon Surgical Video Symposium: Surgeons will showcase their experience with UNITY VCS in cataract and vitreoretinal procedures through live discussion and videos.
  4. Alcon Global Medical Affairs Symposium: Vaishali Vasavada, MBBS, MS, will moderate the session, which will look at meaningful real-world evidence supporting the use of the Vivity IOL in special populations.

“We are excited that India is hosting APACRS for the second time. The event is an ideal platform to showcase our breakthrough technologies like the Advanced Technology IOL portfolio and UNITY VCS/CS, and foster meaningful exchange amongst ECPs,” Amar Vyas, Country Head, Alcon India, said in a press release.1

“As cataract procedures rise, it’s critical that advanced technologies are both clinically proven across diverse patient populations and accessible to those who need them. We remain committed to empowering surgeons with science-backed solutions that elevate surgical precision and patient outcomes.”

Reference:
  1. Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS. August 18, 2025. https://www.businesswire.com/news/home/20250818783931/en/Alcon-Underscores-Benefits-of-Its-IOLs-and-Cataract-Surgical-Equipment-at-APACRS Accessed August 21, 2025.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
© 2025 MJH Life Sciences

All rights reserved.